1. Home
  2. POCI vs GBIO Comparison

POCI vs GBIO Comparison

Compare POCI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

N/A

Current Price

$4.08

Market Cap

32.4M

Sector

Health Care

ML Signal

N/A

Logo Generation Bio Co.

GBIO

Generation Bio Co.

N/A

Current Price

$5.35

Market Cap

36.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POCI
GBIO
Founded
1982
2016
Country
United States
United States
Employees
90
115
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
POCI
GBIO
Price
$4.08
$5.35
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.88
AVG Volume (30 Days)
22.9K
46.6K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,575,039.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.67
N/A
52 Week Low
$3.77
$3.00
52 Week High
$5.34
$12.50

Technical Indicators

Market Signals
Indicator
POCI
GBIO
Relative Strength Index (RSI) 42.59 53.25
Support Level $4.04 $5.20
Resistance Level $4.30 $5.54
Average True Range (ATR) 0.25 0.25
MACD -0.02 0.04
Stochastic Oscillator 17.13 71.19

Price Performance

Historical Comparison
POCI
GBIO

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: